Pacira BioSciences (PCRX) Other Operating Expenses (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Other Operating Expenses of $2.3 million for Q1 2026, up 136.8% year-over-year from $961558.9 in Q1 2025, and down 95.9% quarter-over-quarter from $55.5 million in Q4 2025.
Pacira BioSciences (PCRX) Other Operating Expenses (2010 - 2026) Analysis & Trends
Pacira BioSciences' Other Operating Expenses history runs 17 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- In Q1 2026, Other Operating Expenses rose 136.8% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $169.0 million (down 48.27% YoY), while the FY2025 annual figure was $221.1 million, down 44.53% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $2.3 million, down from $55.5 million in the prior quarter.
- The five-year high for Other Operating Expenses was $213.5 million in Q3 2024, with the low at -$12.1 million in Q1 2023.
- The 5-year median for Other Operating Expenses is $55.5 million (2025), against an average of $48.6 million.
- The sharpest annual moves came in 2022 and 2023: Other Operating Expenses jumped 12468.49% in 2022, then plunged 179.16% in 2023.
- Pacira BioSciences' Other Operating Expenses stood at $100.4 million in 2022, then slumped by 37.42% to $62.8 million in 2023, then declined by 6.01% to $59.0 million in 2024, then decreased by 6.04% to $55.5 million in 2025, then sank by 95.9% to $2.3 million in 2026.
- Business Quant data shows PCRX's Other Operating Expenses at $2.3 million in Q1 2026, $55.5 million in Q4 2025, and $55.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Pacira BioSciences | 946.10 Mn | 695.07 Mn | 148.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.59 Mn |
| Mar 31, 2026 | 2.28 Mn |
| Dec 31, 2025 | 55.47 Mn |
| Sep 30, 2025 | 55.39 Mn |
| Jun 30, 2025 | 55.82 Mn |
| Mar 31, 2025 | -6.19 Mn |
| Dec 31, 2024 | 59.04 Mn |
| Sep 30, 2024 | 213.47 Mn |
| Jun 30, 2024 | 60.32 Mn |
| Mar 31, 2024 | 63.64 Mn |
| Dec 31, 2023 | 62.81 Mn |
| Sep 30, 2023 | 57.26 Mn |
| Jun 30, 2023 | 45.92 Mn |
| Mar 31, 2023 | -12.11 Mn |
| Dec 31, 2022 | 100.37 Mn |
| Sep 30, 2022 | -489,000.00 |
| Jun 30, 2022 | 18.06 Mn |
| Mar 31, 2022 | -4.34 Mn |
| Dec 31, 2021 | 87.32 Mn |
| Sep 30, 2021 | -237,000.00 |